Page last updated: 2024-11-03

prazosin and Fibrosarcoma

prazosin has been researched along with Fibrosarcoma in 2 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Fibrosarcoma: A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burney, IA2
Maxwell, RJ2
Field, SB2
McCoy, CL1
Griffiths, JR2

Other Studies

2 other studies available for prazosin and Fibrosarcoma

ArticleYear
Effect of vasoactive drugs on tumour blood flow as determined by 2H nuclear magnetic resonance spectroscopy.
    Acta oncologica (Stockholm, Sweden), 1995, Volume: 34, Issue:3

    Topics: Animals; Blood Pressure; Body Water; Calcitonin Gene-Related Peptide; Cell Hypoxia; Deuterium; Deute

1995
The potential for prazosin and calcitonin gene-related peptide (CGRP) in causing hypoxia in tumours.
    British journal of cancer, 1991, Volume: 64, Issue:4

    Topics: Animals; Blood Pressure; Calcitonin Gene-Related Peptide; Cell Hypoxia; Fibrosarcoma; Magnetic Reson

1991